LAUSANNE, Switzerland, Sept. 03, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced participation in two investor conferences in September: H.C. Wainwright 26th Annual Global Investment Conference Date: September 9, 2024Presentation Time: 7:00 a.m. ETFormat: Virtual Fireside Chat Speaker: Ameet Mallik, Chief Executive Officer 10th Cantor Global Healthcare Conference 2024 Date: September 18, ...